MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jha2.516

Медицинская библиотека · EJHaem · 2022

Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis.

Abroud Hajer, Beldi-Ferchiou Asma, Audard Vincent, Lemonnier François, Le Bras Fabien, Belhadj Karim, Moktefi Anissa, Poullot Elsa, El Karoui Khalil, Dupuis Jehan, Maarek Alizée, Roulin Louise, Delfau-Larue Marie-Hélène, Oghina Silvia, Kharoubi Mounira, Bézard Mélanie, Zaroui Amira, Damy Thibaud, Molinier-Frenkel Valérie

СтатьяПеревод пока не подготовлен

Аннотация

The causal protein of amyloid light-chain (AL) amyloidosis is a monoclonal immunoglobulin free light chain (mFLC), which must be quantified in the serum for patient diagnosis and monitoring. Several manufacturers commercialize immunoassays that quantify total kappa (κ) and lambda (λ) FLC, but results can differ greatly between these tests. Here, we compared a recently developed enzyme-linked immunosorbent assay (ELISA) (Sebia) with N-Latex immunonephelometry (Siemens) in 96 patients diagnosed with AL amyloidosis (histologically confirmed) and 48 non-AL patients sent to our referral center for suspicion of cardiac amyloidosis. ELISA free-light chain difference (dFLC) were lower than N-Latex values, and agreement between methods was reduced in the case of involved λ FLC. Diagnosis sensitivity and specificity were >85% with both assays. A receiver operating characteristic analysis indicated that ELISA performances could be improved by using a higher value for the lower limit of the κ/λ ratio. We also assessed Freelite (The Binding Site) in a subgroup of these same AL patients, including 18 cases with normal κ/λ ratio by at least one assay. Only two patients had normal κ/λ ratio with all three assays. Overall, ELISA demonstrated slightly lower sensitivity than N-Latex but may be an alternative to nephelometry/turbidimetry in certain difficult cases.

Для цитирования: Abroud Hajer, Beldi-Ferchiou Asma, Audard Vincent, Lemonnier François, Le Bras Fabien, Belhadj Karim, Moktefi Anissa, Poullot Elsa, El Karoui Khalil, Dupuis Jehan, Maarek Alizée, Roulin Louise, Delfau-Larue Marie-Hélène, Oghina Silvia, Kharoubi Mounira, Bézard Mélanie, Zaroui Amira, Damy Thibaud, Molinier-Frenkel Valérie. Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis.. EJHaem. 2022. DOI: 10.1002/jha2.516.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.